Skip to main content
SpringerLink
Log in

Klinisch bedeutsame Wechselwirkungen der Psychopharmaka

  • Chapter
Psychopharmaka

Zusammenfassung

Unter Wechselwirkungen von Arzneimitteln werden erwünschte und unerwünschte Wirkungen verstanden, die nur bei gleichzeitiger Gabe zweier oder mehrerer Arzneimittel auftreten. Bisweilen wird der Begriff Arzneimittelinteraktion allein auf die unerwünschten Wirkungen begrenzt, die aus Kombinationen resultieren. Allgemein und insbesondere in der Psychopharmakotherapie sind jedoch erwünschte und unerwünschte klinische Wirkungen nicht absolut definierbar. So können zum Beispiel sedierende Pharmakowirkungen je nach therapeutischer Zielsetzung erwünscht oder unerwünscht sein. Deshalb erscheint es uns sinnvoll, Wechselwirkungen unter dem Aspekt der Psychopharmakotherapie etwas weiter zu definieren. Unter Arzneimittelinteraktionen sollen hier alle klinisch bedeutsamen Wirkungen verstanden werden, die sich aus einer Kombinationsbehandlung mit Psychopharmaka ergeben, die entweder auf eine verbesserte therapeutische Wirkung oder auf eine Verminderung von unerwünschten Wirkungen abzielt. Wesentlich für die Begriffsdefinition ist, daß unter Interaktionen nicht nur Verstärkungen oder Abschwächungen des ursprünglich oder zusätzlich verabreichten Medikaments verstanden werden, sondern auch das Auftreten von neuen Wirkungen.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 64.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 84.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Anden, N. E., Butcher, S., Corrodi, H., Fuxe, K., Ungerstedt, U. (1970): Receptor activity and turnover of dopamine and noradrenaline after neuroleptics. Eur. J. Pharmac. 71, 303–315.

    Google Scholar 

  2. Ananth, J., Luchins, D. (1977): A review of combined tricyclic and MAO-inhibitor therapy. Compr. Psychiat. 18, 221–230.

    PubMed  CAS  Google Scholar 

  3. Baldessarini, R. J., Lipinski, J. F. (1976): Toxicity and side effects of antipsychotic, antimanic and antidepressant medications. Psychiat. Ann. 6, 484–493.

    Google Scholar 

  4. Becker, R. E. (1970): Evaluation of an amitriptyline-perphenazine combination in chronic schizophrenia. Am. J. Psychiat. 127, 127–131.

    Google Scholar 

  5. Beckmann, H., Goodwin, F. K. (1975): Antidepressant response to tricyclics and urinary MHPG in unipolar patients: Clinical response to imipramine or amitriptyline. Arch. Gen. Psychiat. 32, 17–21.

    PubMed  CAS  Google Scholar 

  6. Bielski, R. J., Friedel, R. O. (1976): Prediction of tricyclic antidepressant response: A critical review. Arch. Gen. Psychiat. 33, 1479–1489.

    PubMed  CAS  Google Scholar 

  7. Blackwell, B., Price, J., Taylor, D. (1967): Hypertensive interactions between monoamine oxidase inhibitors and foodstuffs. Br. J. Psychiat. 113, 349–365.

    CAS  Google Scholar 

  8. Bowers, M. B., jr. (1973): 5-hydroxyindoleacetic acid (5HIAA) and homovanillie acid (HVA) following probenecid in acute psychotic patients treated with phenothiazines. Psychopharmacol. 28, 309–318.

    Google Scholar 

  9. Burrows, G. D., Vohra, J., Hunt, D., Sloman, J. G., Scoggins, B. A., Davies, B. (1977): Cardiac effects of different tricyclic antidepressant drugs. Br. J. Psychiat. 130, 335–341.

    Google Scholar 

  10. Butterworth, A. T. (1972): Inhibition of extrapyramidal side effects of haloperidol through the joint use of imipramine-type drugs. Psychosomatics 13, 328–332.

    PubMed  CAS  Google Scholar 

  11. Breastrup, C., Scheel-Krüger, J. (1976): Methylphenidate-like effects of the new antidepressant drug nomifensine (HOE 984). Eur. J. Pharmac. 38, 305–259.

    Google Scholar 

  12. CarlssonA. (1978): Mechanism of action of neuroleptic drugs. In: Psychopharmacology: A Generation of Progress ( Lipton, M. A., DI Mascio, D., Killam, K. F., Hrsg.), S. 1057–1070. New York: Raven Press.

    Google Scholar 

  13. Casey, J. F., Hollister, L. E., Klett, C. J., Lasky, J. J., Caffey, E. M. (1961). Combined drug therapy of chronic schizophrenics. Am. J. Psychiat. 117, 997–1003.

    PubMed  CAS  Google Scholar 

  14. Cheng, S. F., Fogel, E. J. (1963): Trifluoperazine combined with amitriptyline in paranoid psychotics. Am. J. Psychiat. 119, 780–781.

    PubMed  CAS  Google Scholar 

  15. Chien, C. P., Cole, J. O. (1973): Depot phenothiazine treatment in acute psychosis. Am. J. Psychiat. 130, 13–17.

    PubMed  CAS  Google Scholar 

  16. Chouinard, G., Annable, L., Serrano, M., Albert, J. M., Charette, R. (1975): Amitriptyline-perphenazine interaction in ambulatory schizophrenic patients. Arch. Gen. Psychiat. 32, 1295–1307.

    PubMed  CAS  Google Scholar 

  17. Cohen, W. J., Cohen, N. H. (1974): Lithium carbonate, haloperidoI, and irreversible brain damage. J. Am. Med. Assoc. 230, 1283–1287.

    CAS  Google Scholar 

  18. Collins, A. D., Dundas, J. (1967): A double-blind trial of amitriptyline-perphenazine, perphenazine and placebo in chronic withdrawn inert schizophrenics. Br. J. Psychiat. 113, 1425–1429.

    CAS  Google Scholar 

  19. Cooper, S. F., Dugal, R., Elie, R., Albert, J. M. (1979): Metabolic interaction between amitriptyline and perphenazine in psychiatric patients. Prog. Neuro-Psychopharmacol. 3, 369–376.

    CAS  Google Scholar 

  20. Creese, J., Burt, R. D., Snyder, H. S. (1978): Biochemical actions of neuroleptic drugs: Focus on the dopamine receptor. In: Handbook of Psychopharmacology, Vol. 10: Neuroleptics and Schizophrenia ( Iversen, L. L., Iversen, S. D., Snyder, G. S., Hrsg.). New York - London: Plenum Press.

    Google Scholar 

  21. Davis, J. M. (1968): Overdosage of psycho-tropic drugs: a review. Dis. nerv. Syst. 29, 246–256.

    CAS  Google Scholar 

  22. Dugal, R., Caille, G., Albert, J.-M., Cooper, S. F. (1975): Apparent pharmacokinetic interaction of diazepam and amitriptyline in psychiatric patients. Curr. Ther. Res. 18, 679–686.

    PubMed  CAS  Google Scholar 

  23. Eibergen, R. D., Carlson, K. R. (1976): Pharmacol. Biochem. Behav, 5, 175–188.

    CAS  Google Scholar 

  24. Elyousef, M. D., Manier, D. H. (1974): Tricyclic antidepressants and phenothiazines, J. Am. Med. Assoc. 229, 1419.

    CAS  Google Scholar 

  25. Freeman, H. (1967): The therapeutic value of combinations of psychotropic drugs, Psychopharmacol. Bull. 4, 1–27.

    CAS  Google Scholar 

  26. Freeman, H. (1970): The utility of psychotic drug combinations. In: Clinical Handbook of Psychopharmacology ( Dimascio, A., Shader, R. I., Hrsg.). New York: Jason Aronson.

    Google Scholar 

  27. Gander, D. R. (1965): Treatment of depressive illnesses with combined antidepressants. Lancet 2, 107–108.

    Google Scholar 

  28. General Practitioner Research Group (1969): Combined therapy in neurotic depression. Practitioner 199, 814–816.

    Google Scholar 

  29. General Practitioner Research Group (1969): Chlordiazepoxide with amitriptyline in neurotic depression. Practitioner 202, 437–440.

    Google Scholar 

  30. Gershon, S., Holmberg, G., Mattson, E., et al. (1962): Imipramine hydrochloride, autonomic and physiological functions. Arch. Gen. Psychiat. 6, 112–117.

    Google Scholar 

  31. Glenn, A. G., Crayton, J. W., Klass, D. B., Evans, H., Strizich, M. (1979): Lithium in chronic schizophrenia. Am. J. Psychiat. 136, 454–455.

    Google Scholar 

  32. Goldberg, R. S., Thornton, W. E. (1978): Combined tricyclic-MAOI therapy for refractory depression. J. Clin. Pharmacol. 18. 2–3, 143–147.

    Google Scholar 

  33. Gram, L. F., Christiansen, J., Fredricson Overo, K., (1972): Pharmacokinetic interaction between neuroleptics and tricyclic antidepressants, Psychopharmacol. Suppl., 80.

    Google Scholar 

  34. Gram, L. F., Fredricson Overo, K. (1972): Drug interaction: inhibitory effect of neuroleptics on metabolism of tricyclic antidepressants in man. Brit. Med. J. 1, 463–465.

    PubMed  CAS  Google Scholar 

  35. Gram, L. F., Christiansen, J., Frederic-Son Overf, K. (1973): Pharmacokinetic interaction between tricyclic antidepressants and other psychopharmaca, Acta Psychiat. Scand., Suppl. 243, 52–53.

    Google Scholar 

  36. Gram, L. F., Reisby, N., Ibsen, I., Nagy, A., Dencker, S. J., Bech, R., Odden Petersen, G., Christiansen, J. (1976): Plasma levels and antidepressive effect of imipramine. Clin. Pharmacol. Ther. 19, 318–324.

    PubMed  CAS  Google Scholar 

  37. Greenblatt, M., Grosser, G. H., Wechsler, H. (1964): Differential response of hospitalized depressed patients to somatic therapy. Am. J. Psychiat. 120, 934–943.

    Google Scholar 

  38. Grohmann, R., Strauss, A., Gehr, CH., Rüther, E., Hippius, H. (1980): Zur Praxis der klinischen Therapie mit Psychopharmaka. Pharmakopsychiat. 13, 1–19.

    CAS  Google Scholar 

  39. Guz, I., Moraes, R., Sartoretto, I. N. (1972): The therapeutic effect of lorazepam in psychotic patient treated with haloperidol. Curr. Ther. Res. 14, 767–774.

    PubMed  CAS  Google Scholar 

  40. Haider, J. (1967): A comparative trial of Ro 4–6270 and amitriptyline in depressive illness. Br. J. Psychiat. 113, 993–998.

    CAS  Google Scholar 

  41. Hanlon, T. E., Ota, K. Y., Agallianos, D. D., Bergmann, S. A., Bethon, G. D., Kobler, F., Kurland, A. A. (1969): Combined drug treatment of newly hospitalized acutely ill psychiatric patients. Dis. nerv. Syst. 30, 104–116.

    CAS  Google Scholar 

  42. Hanlon, T. E., Ota, K. Y., Kurland, A. A. (1970): Comparative effects of fluphena- zine, fluphenazine-chlordiazepoxide and fluphenazine-imipramine. Dis. nerv. Syst. 31, 171–177.

    CAS  Google Scholar 

  43. Hedberg, D. L., Houck, J. H., Glueck, B. C., Jr. (1971): Tranylcypromine-trifluoperazine-combination in the treatment of schizophrenia. Am. J. Psychiat. 127, 1141–1146.

    PubMed  CAS  Google Scholar 

  44. Himmelhoch, I. M., Detre, T., Kupfer, D. J., Swartzburg, M., Byck, R. (1972): Treatment of previously intractable depressions with tranylcypromine and lithium. J. nerv. ment. Dis. 155, 216–220.

    PubMed  CAS  Google Scholar 

  45. Hippius, H. (1979): Geriatrie, Psychiatrie, S. 118–125. Berlin–Heidelberg–New York: Springer.

    Google Scholar 

  46. Hollister, L. E., Overall, J. E., Johnson, M. H., Shelton, J., Kimbell, I., Brunse, A. (1966): Amitriptyline alone and combined with perphenazine in newly admitted depressed patients. J. Nerv. Ment. Dis. 142, 460–469.

    PubMed  CAS  Google Scholar 

  47. Hollister, L. E., Overall, J. E., Shelton, J., Pennington, V., Kimbell, T., Johnson, M. (1967): Drug therapy of depression: amitriptyline, perphenazine and their combinations in different syndromes. Arch. Gen. Psychiat. 17, 486–493.

    PubMed  CAS  Google Scholar 

  48. Houck, J. E. (1970): Combined therapy in anxiety-depressive syndromes, I. comparative effects of limbitrol (chlordiazepoxide-amitriptyline) and placebo. Dis. nerv. Syst. 31, 269–273.

    CAS  Google Scholar 

  49. Hordern, A., Somerville, D. M. (1963): Clinical trials in chronic schizophrenia. Med. J. Aust. 1, 40–43.

    Google Scholar 

  50. Hordern, A., Somerville, D. M. Krupinski, J. (1962): Does chronic schizophrenia respond to a combination of a neuroleptic and an antidepressant? J. Nerv. Ment. Dis. 134, 361–376.

    PubMed  CAS  Google Scholar 

  51. Horwitz, W. A. (1968): Physiologic responses as prognostic guides in the use of antidepressant drugs. Am. J. Psychiat. 125, 60–68.

    PubMed  CAS  Google Scholar 

  52. Jarecki, H. G. (1963): Combined amitriptyline and phenelzine poisoning. Am. J. Psychiat. 120, 189.

    Google Scholar 

  53. Johnson, G., Gershon, S., Hekimian, L. J. (1968): Controlled evaluation of lithium and chlorpromazine in the treatment of manic states: an interim report. Compr. Psychiat. 9, 563–573.

    PubMed  CAS  Google Scholar 

  54. Kalinowsky, L. B., Hippius H., Klein, H. E. (1982): Novel antidepressant drugs. In: Biological Treatments in Psychiatry, S. 142. Grune & Stratton.

    Google Scholar 

  55. Kay, D. W. K., Garside, R. F., Fahy, T. J. (1974): A double blind trial of phenelzine and amitriptyline in depressed out-patients. Br. J. Psychiat. 124, 219–226.

    CAS  Google Scholar 

  56. Kielholz, P., Terzani, S., Gastpar, M., Adams, C. (1981): Behandlung therapieresistenter Depressionen ohne Elektroschock. Dtsch. med. Wschr. 106, 671–673.

    CAS  Google Scholar 

  57. Klein, D. F., Fink, M. (1962): Psychiatric reaction patterns to imipramine. Am. J. Psychiat. 119, 432–438.

    PubMed  CAS  Google Scholar 

  58. Krishna, N. R., Taylor, M. A., Abrams, R. (1978): Combined haloperidol and lithium carbonate in treating manic patients. Compr. Psychiat. 19, 119–120.

    PubMed  CAS  Google Scholar 

  59. Kuss, H. J., Jungkunz, G., Dieterle, D. (1980): Veränderung der klinischen Wirkung des Amitriptylins durch Kombinationsbehandlung. Arzneim.-Forsch./Drug. Res. 20, 1200.

    Google Scholar 

  60. Lamy, P. P., Kittler, M. E. (1971): Untoward effect of drugs, part II. Dis. nerv. Syst. 32, 105–114.

    CAS  Google Scholar 

  61. Lingjaerde, O. (1973): Synergistic effect of tricyclic antidepressants and lithium carbonate in endogenous depression. Lancet ii:, 1260.

    Google Scholar 

  62. Lowney, J. F., Cedarleaf, C. B. (1969): Double-blind evaluation of an amitriptyline-fluphenazine combination. Curr. Ther. Res. 11, 271–277.

    PubMed  Google Scholar 

  63. Man, P. L., Aleem, A. (1972): Are MAOI and other psychotropic drugs really compatible ? Br. J. Psychiat. 120, 120–121.

    CAS  Google Scholar 

  64. Maas, W. J. (1978): Clinical implications of pharmacological differences among antidepressants. In: Psychopharmacology: A Generation of Progress ( Lipton, M. A., Dimascio, A., Killan, K. F., Hrsg.), New York: Raven Press.

    Google Scholar 

  65. Mena, A., Heistad, G., Schiele, B. C., Janecek, J. (1964): A comparison of tranylcypromine alone with tranylcypromine plus trifluoperazine in the treatment of chronic outpatients. J. Neuropsychiat. 5, 542–550.

    PubMed  CAS  Google Scholar 

  66. Merlis, S., Sheppard, CH: (1978): Polypharmacy: Questions of incidence, perference, and evidence of efficacy. In: Principles of Psychopharmacology (CLARK, G. W. DEL GUIDICE, J., Hrsg.), Kap. 35. New York - San Francisco - London: Academic Press.

    Google Scholar 

  67. Michaux, M. H., Kurland, A. A. (1963): Combined psychotropic drug therapy. Dis. Nerv. Syst. 24, 739–741.

    PubMed  CAS  Google Scholar 

  68. Michaux, M. H., Kurland, A. A., Agallianos, D. D. (1966): Chlorpromazine-chlordiazepoxide and chlorpromazine-imipramine treatment of newly hospitalized, acutely ill psychiatric patients. Curr. Ther. Res. 8, suppl., 117–152.

    Google Scholar 

  69. Démontigny, C., Grunberg, F., Mayer, A., Descheues, J. P. (1981): Lithium induces rapid relief of depression in tricyclic antidepressant drug nonresponders. Br. J. Psychiat. 138, 252–256.

    Google Scholar 

  70. Morris, J. B., Beck, A. T. (1974): The efficacy of antidepressant drugs. Arch. Gen. Psychiat. 30, 667–674.

    PubMed  CAS  Google Scholar 

  71. Moller-Oerlinghausen, B. (1978): Antidepressive Langzeitmedikation, unter besonderer Berücksichtigung der Lithiumsalze. Nervenarzt 49, 507–517.

    Google Scholar 

  72. Müller-Oerlinghausen, B. (1978): Interactions between Lithium and other psycho-tropic drugs (Proceedings of the Xth CINP Congress). Neuro-Psychopharmacol. 2., S. 1085–1094. Pergamon Press.

    Google Scholar 

  73. Nagy, A., Johansson, R. (1977): The demethylation of imipramine and clomipramine as apparent from their plasma kinetics. Psychopharmacol. 54, 125–131.

    CAS  Google Scholar 

  74. O’Flanagan, P. M. (1973): Clomipramine infusion and lithium carbonate: a synergistic effect? Lancet ii:, 974.

    Google Scholar 

  75. Olivier-Martin, R., Marzin, D., Buschsenschutz, E., Pichot, P., Boissier, A. J. (1975): Concentrations plasmatiques de l’imipramine et de la desmethylimipramine et effet ante-depresseur au cours d’un trait-ment controlé. Psychopharmacol. 41, 187–195.

    Google Scholar 

  76. Oltmann, J. F., Friedman, S. (1966): Perphenazine-amitriptyline in the treatment of schizophrenia. Am. J. Psychiat. 123, 607–609.

    Google Scholar 

  77. Pare, C. M. B. (1977): Monoamine oxidase inhibitors: a personal account. In: Handbook of Studies on Depression (Burrows, G. D., Hrsg.), S. 195–213. Amsterdam: Excerpta Medica.

    Google Scholar 

  78. Prien, R. F., Klett, J. C. Caffey, E. M. (1976): Polypharmacy in the psychiatric treatment of elderly hospitalized patients: a survey of 12 veterans administration hospitals. Dis. nerv. Syst. 37, 333–336.

    Google Scholar 

  79. Rand, M. J., MC, Culloch, M. W. (1977): Modes of action of antidepressants. In: Handbook of Studies on Depression (Burrows, G. D., Hrsg.), S. 137–155. Amsterdam: Excerpta Medica.

    Google Scholar 

  80. Rickels, K., Gordon, P. E., Jenkins, W., Perloff, M., Sachs, T., Stepansky, W. (1970): Drug treatment in depressive illness (Amitriptyline and chlordiazepoxide in two neurotic populations). Dis. nerv. Syst. 31, 30–42.

    CAS  Google Scholar 

  81. Rickels, K., Hesbacher, P., Downing, R. W. (1970): Differential drug effect in neurotic depression. Dis. nerv. Syst. 31, 468–475.

    CAS  Google Scholar 

  82. Rickels, K., Raab, E., De Silverio, R., Etemad, B. (1967): Drug treatment in depression: antidepressant or tranquilizer? J. Am. Med. Assoc. 201, 675–681.

    CAS  Google Scholar 

  83. Roth, S. (1970): The seemingly ubiquitous depression following acute schizophrenic episodes, a neglected area of clinical discussion. Am. J. Psychiat. 127, 91–98.

    Google Scholar 

  84. Rother, E. (1976): Interaction of neuroleptic clozapine and haloperidol. (Submitted to Proceedings of CINP Congress, Quebec 1976.)

    Google Scholar 

  85. Sargant, W. (1965): Combining the antidepressant drugs. Br. Med. J. 1, 251.

    PubMed  CAS  Google Scholar 

  86. Sargant, W. (1971): Safety of combined antidepressant drugs. Br. Med. J. 1, 555–556.

    PubMed  CAS  Google Scholar 

  87. Schiele, B. C., Vestre, N. C., McNaughton, D. V. (1963): Treatment of hospitalized schizophrenics with trifluoperazine plus tranylcypromine. Compr. Psychiat. 4, 66–79.

    PubMed  CAS  Google Scholar 

  88. Schildkraut, J. J. (1973): Norepinephrine metabolites as biochemical criteria for classifying depressive disorders and predicting responses to treatment: preliminary findings. Am. J. Psychiat. 130, 695–698.

    PubMed  CAS  Google Scholar 

  89. Schou, M. (1974): Heutiger Stand der Lithium-Rezidivprophylaxe bei endogenen affektiven Erkrankungen. Nervenarzt 45, 397–418.

    PubMed  CAS  Google Scholar 

  90. Schroeder, N. H., Caffey, E. M., Lorei, T. W. (1977): Antipsychotic drug use: physican prescribing practics in relation to current recommendations. Dis. nerv. Syst. 38, 114–116.

    CAS  Google Scholar 

  91. Schuckit, J., Robins, E., Feighner, J. (1971): Tricyclic antidepressants and monoamine oxidase inhibitors: combination therapy in the treatment of depression. Arch. Gen. Psychiat. 24, 509–514.

    PubMed  CAS  Google Scholar 

  92. Seeman, P., Chan-Wong M., Sidney, CH.-W. M., Tedesco, J., Wong, K. (1975): Brain receptors for antipsychotic drugs and dopamine: direct binding assay. Proc. Natl. Acad. Sci. USA 72, 76–80.

    Google Scholar 

  93. Sedvall, G., Fyro, B., Nyback, H., Wiesel, F. A. (1975): Actions of dopaminergic antagonists in the striatum. In: Advances in Neurology, Vol. 9 ( Calve D. B., Chase, T. N., Barbeau A., Hrsg.), S. 131–140. New York: Raven Press.

    Google Scholar 

  94. Sethna, E. R. (1974): A study of refractory cases of depressive illnesses and their response to combined antidepressant treatment, Br. J. Psychiat. 124, 265–272.

    CAS  Google Scholar 

  95. Shanfield, S., Tucker, G. J., Harrow, M., et al. (1970): The schizophrenic patient and depressive symptomatology. J. Nerv. Ment. Dis. 151, 203–210.

    PubMed  CAS  Google Scholar 

  96. Sharpley, P., Mena, A., Schiele, B. C., Heistad C. (1964): A comparison of pargyline and tranylcypromine with and without the addition of trifluoperazine. Curr. Ther. Res. 6, 344–352.

    PubMed  CAS  Google Scholar 

  97. Sheppard, C., Beyel, V., Fracchia, J., Merlis, L. (1974): Polypharmacy in psychiatry: a multi-state comparison of psychotropic drug combinations. Dis. nerv. Syst. 35, 183–189.

    CAS  Google Scholar 

  98. Sheppard, C., Collins, L., Fiorentino, D., Fracchia, J., Merlins, S. (1969): Poly-pharmacy in psychiatric treatment: I. I.cidence at a state hospital. Curr. Ther. Res. 11, 765–774.

    PubMed  CAS  Google Scholar 

  99. Shopsin, B., Small, J. G., Kellams, J. J., Milstein, V., Moore, J. E. (1976). Combining lithium and neuroleptics. Am. J. Psychiat. 133, 980–981.

    Google Scholar 

  100. De Silverio, R. V., Rickels, K., Weise, C. C., Clarc, E. L., Hutchinson, J. (1970): Perphenazine-amitriptyline in neurotic depressed outpatients. Am. J. Psychiat. 127, 322–328.

    Google Scholar 

  101. Silverman, G., Braithwaite, R. A., (1972): Interaction of benzodiazepines with tricyclic antidepressants. Br. Med. J. 4, 111.

    PubMed  CAS  Google Scholar 

  102. Silverman, G., Braithwaite, R. A. (1973): Benzodiazepines and tricyclic antidepressant plasma levels. Br. Med. J. 3, 18–20.

    PubMed  CAS  Google Scholar 

  103. Simpson, G. M., Krakov, B. L., Kunzbartholini, E. (1970): A controlled trial of combined medications on behavioral and extrapyramidal effects. Acta Psychiat. Scand. 212, suppl. 20-27.

    CAS  Google Scholar 

  104. Simpson, L. L., Cabot, B. (1976): Mono amine oxidase inhibitors. In: Drug Treatment of Mental Disorders (Simpson, G. M., Hrsg.), S. 147–160. New York: Raven Press.

    Google Scholar 

  105. Siris, S. G., Van Kammen, D. P., Docherty, J. P. (1978): Use of antidepressant drugs in schizophrenia. Arch. Gen. Psychiat. 35, 1368–1377.

    PubMed  CAS  Google Scholar 

  106. Snowdon, J. A. (1976): Doppel-Blind-Studie über dreimalige Tages-und einmalige Nachtverabreichung von Amitriptylin unter spezieller Berücksichtigung von Nebenwirkungen. Curr. Med. Res. Opin. 4, 381–387.

    PubMed  CAS  Google Scholar 

  107. Spiker, D. G., Pugh, D. D. (1976): Combining tricyclic and monoamine oxidase inhibitor antidepressants. Arch. Gen. Psychiat. 33, 828–830.

    PubMed  CAS  Google Scholar 

  108. Talbot, D. R. (1964): Are tranquilizer combinations more effective than a single tranquilizer ? Am. J. Psychiat. 121, 597–600.

    PubMed  CAS  Google Scholar 

  109. Vandel, B., Vandel, S., Allers, G., Bechtel, P., Volmat, R. (1979): Interactions between amitriptyline and phenothiazine in man: effect on plasma concentration of Amitriptyline and its metabolite nortriptyline and the correlation with clinical response. Psychopharmacol. 65, 187–190.

    CAS  Google Scholar 

  110. Vestre, N. D., Dehnel, L. L., Schiele, B. C. (1969): A sequential comparison of amitriptyline, perphenazine and the amitriptyline-perphenazine combination in recently admitted anergic schizophrenics. Psychosomatics 10, 296–303.

    PubMed  CAS  Google Scholar 

  111. Vogt, A. H. (1961): The use of stelazine and parnate in chronic, withdrawn patients. Am. J. Psychiat. 118, 256–257.

    PubMed  CAS  Google Scholar 

  112. Warnes, H., Lehmann, H. E., Ban, T. A. (1967): A dynamic ileus during psychoactive medication: a report of three fatal and five severe cases. Canad. Med. Assoc. J. 96, 1112–1113.

    PubMed  CAS  Google Scholar 

  113. Winstead, D. K., Blackwell, B., Eilers, M. K. (1976): Psychotropic drugs use in five city hospitals. Dis. nerv. Syst. 37, 504–509.

    CAS  Google Scholar 

  114. Winston, F., (1972): Compatibility of MAOI and other psychotropic drugs. Br. J. Psychiat. 120, 588–589.

    CAS  Google Scholar 

  115. Winston, F. (1971): Combined antidepressant therapy. Br. J. Psychiat. 118, 301–304.

    CAS  Google Scholar 

  116. Winston, F. (1973): Management of a depressive illness. Lancet i:, 147.

    Google Scholar 

  117. Zall, H., Therman, P. O. G., Myers, M. J. (1968): Lithium carbonate: a clinical study. Am. J. Psychiat. 125, 549–554.

    PubMed  CAS  Google Scholar 

  118. Zander, K. J., Rather, E. (1978): Influence of clozapine on neuroleptic extrapyramidal motor disturbance. Drug Res. 28, 1495–1496.

    CAS  Google Scholar 

Download references

Authors
  1. H. E. Klein
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. Rüther
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Psychiatrischen Universitätsklinik Wien, Lazarettgasse 14, A-1097, Wien, Österreich

    Gerhard Langer (Oberarzt) (Oberarzt)

  2. Osianderstraße 22, D-4700, Tübingen 1, Bundesrepublik Deutschland

    Hans Heimann (Ärztlicher Direktor der Psychiatrischen Klinik und Poliklinik der Universität Tübingen) (Ärztlicher Direktor der Psychiatrischen Klinik und Poliklinik der Universität Tübingen)

Rights and permissions

Reprints and permissions

Copyright information

© 1983 Springer-Verlag/Wien

About this chapter

Cite this chapter

Klein, H.E., Rüther, E. (1983). Klinisch bedeutsame Wechselwirkungen der Psychopharmaka. In: Langer, G., Heimann, H. (eds) Psychopharmaka. Springer, Vienna. https://doi.org/10.1007/978-3-7091-7645-0_21

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-7645-0_21

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-7091-7646-7

  • Online ISBN: 978-3-7091-7645-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation